Search Results - Tušková, Liliana

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    MHC II – EGFP knock-in mouse model is a suitable tool for systems and quantitative immunology

    MHC II – EGFP knock-in mouse model is a suitable tool for systems and quantitative immunology by Pačes, Jan, Knížková, Karolina, Tušková, Liliana, Grobárová, Valéria, Zadražil, Zdeněk, Boes, Marianne, Černý, Jan

    Published in Immunology letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    biomarker Driven Strategies for Targeted Elimination of Hypoxia Adapted Lymphoma Cells

    biomarker Driven Strategies for Targeted Elimination of Hypoxia Adapted Lymphoma Cells by Klener, Pavel, Daumová, Lenka, Kazantsev, Dmitry, Anděra, Ladislav, Petrák, Jiří, Dolníková, Alexandra, Bettazová, Nardjas, Kovaříková, Petra, Renešová, Nicol, Tušková, Liliana, Sovilj, Dana, Trněný, Marek, Klanova, Magdalena, Havránek, Ondrej

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Sequencing-Based Analysis of Clonal Evolution of 25 Mantle Cell Lymphoma Patients at Diagnosis and after Failure of Standard Immunochemotherapy

    Sequencing-Based Analysis of Clonal Evolution of 25 Mantle Cell Lymphoma Patients at Diagnosis and after Failure of Standard Immunochemotherapy by Karolova, Jana, Kazantsev, Dmitry, Svaton, Michael, Tušková, Liliana, Forsterova, Kristina, Malarikova, Diana, Benesova, Katerina, Heizer, Tomáš, Dolníková, Alexandra, Klanova, Magdalena, Fronkova, Eva, Trněný, Marek, Klener, Pavel

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A Murine Phase 2 Proof-of-Concept Study of Polatuzumab Vedotin in Combination with Venetoclax in Experimental Therapy of BCL2-Positive Aggressive Lymphomas

    A Murine Phase 2 Proof-of-Concept Study of Polatuzumab Vedotin in Combination with Venetoclax in Experimental Therapy of BCL2-Positive Aggressive Lymphomas by Kazantsev, Dmitry, Pokorna, Eva, Nožičková, Kristýna, Dolníková, Alexandra, Renešová, Nicol, Tuskova, Liliana, Trněný, Marek, Klener, Pavel

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still be Considered the Standard of Care?

    Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still be Considered the Standard of Care? by Tuskova, Liliana, Maláriková, Diana, Benesova, Katerina, Konirova, Eva, Polgarova, Kamila, Blahovcova, Petra, Salkova, Jana, Trněný, Marek, Klener, Pavel

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Comprehensive Genomic Analysis of Non-Relapsed and Late-Relapsed Mantle Cell Lymphoma Patients Compared to Refractory and Early-Relapsed Patients Treated By Standard Immunochemotherapy

    Comprehensive Genomic Analysis of Non-Relapsed and Late-Relapsed Mantle Cell Lymphoma Patients Compared to Refractory and Early-Relapsed Patients Treated By Standard Immunochemothe... by Karolova, Jana, Kazantsev, Dmitry, Winkowska, Lucie, Forsterova, Kristina, Tuskova, Liliana, Malarikova, Diana, Valkova, Veronika, Janikova, Andrea, Obr, Ales, Trneny, Marek, Klener, Pavel

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma

    Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma by Willis, Brandon S., Mongeon, Kevin, Dry, Hannah, Neveras, India L., Bryan, Nadezda, Pandya, Meghana, Roderick-Richardson, Justine, Xu, Wendan, Yang, Li, Rosen, Alan, Reimer, Corinne, Tuskova, Liliana, Klener, Pavel, Mettetal, Jerome T., Lenz, Georg, Barry, Simon T.

    Published in Leukemia
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  8. 8
    Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors

    Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors by Daumova, Lenka, Manakov, Dmitry, Petrak, Jiri, Sovilj, Dana, Behounek, Matej, Andera, Ladislav, Vit, Ondrej, Souckova, Olga, Havranek, Ondrej, Dolnikova, Alex, Renesova, Nicol, Tuskova, Liliana, Winkowska, Lucie, Bettazova, Nardjas, Kupcova, Kristyna, Kalbacova, Marie Hubalek, Sikorova, Miriama, Trneny, Marek, Klener, Pavel

    Published in Cell death discovery
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  9. 9
    Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status

    Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status by Dolnikova, Alexandra, Kazantsev, Dmitry, Klanova, Magdalena, Pokorna, Eva, Sovilj, Dana, Kelemen, Cristina Daniela, Tuskova, Liliana, Hoferkova, Eva, Mraz, Marek, Helman, Karel, Curik, Nikola, Machova Polakova, Katerina, Andera, Ladislav, Trneny, Marek, Klener, Pavel

    Published in Blood advances
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: